Clinical Pharmacology of the Dietary Supplement Creatine Monohydrate
Authors:
- Adam M. PerskyAPAdam M. Persky
- Gayle A. BrazeauGBGayle A. Brazeau
- 1 June 2001
- journal article
- review article
- Published by Elsevier in Pharmacological Reviews
- Vol. 53 (2) , 161-176
Abstract
No abstract availableKeywords
This publication has 113 references indexed in Scilit:
- Creatine Therapy in Myophosphorylase Deficiency (McArdle Disease)Archives of Neurology, 2000
- IS THERE A RATIONALE FOR THE USE OF CREATINE EITHER AS NUTRITIONAL SUPPLEMENTATION OR DRUG ADMINISTRATION IN HUMANS PARTICIPATING IN A SPORT?Pharmacological Research, 2000
- Brain water diffusion in normal and creatine-supplemented rats during transient global ischemiaMagnetic Resonance in Medicine, 1999
- Proton MRS of oral creatine supplementation in rats. Cerebral metabolite concentrations and ischemic challengeNMR in Biomedicine, 1999
- Creatine and Cyclocreatine Attenuate MPTP NeurotoxicityExperimental Neurology, 1999
- Effects of Chronic Dietary Creatine Feeding on Cardiac Energy Metabolism and on Creatine Content in Heart, Skeletal Muscle, Brain, Liver and KidneyJournal of Molecular and Cellular Cardiology, 1998
- A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathiesMuscle & Nerve, 1997
- The regulation of total creatine content in a myoblast cell lineMolecular and Cellular Biochemistry, 1996
- The Cloning and Expression of a Human Creatine TransporterBiochemical and Biophysical Research Communications, 1994
- The Putative Rat Choline Transporter CHOT1 Transports Creatine and Is Highly Expressed in Neural and Muscle-Rich TissuesBiochemical and Biophysical Research Communications, 1994